Introduction About MYTREXATE 2.5 TABLET

MYTREXATE 2.5 TABLET is also used to manage its polyarthritic forms (characterized by the involvement of five or more joints), which are severe, active, and idiopathic in nature and affect young people (Juvenile Idiopathic Arthritis, JIA).

MYTREXATE 2.5 TABLET is also used to manage psoriasis and relapsed (reoccurred) and refractory (unaffected by other conventional managements) Non-Hodgkin’s lymphoma, which is a type of cancer of the lymphatic system.

Psoriasis is a skin condition characterized by itchy scales that is not responsive to conventional managements such as phototherapy and retinoids.

Before taking MYTREXATE 2.5 TABLET, it is recommended to inform the doctor about your medical and family history, including the list of medicines (prescription, non-prescription medicines, and herbal medicines) that are being taken.

Also, MYTREXATE 2.5 TABLET is not recommended to be taken by pregnant and nursing women, women planning pregnancy, those who drink huge amounts of alcohol, or patients suffering from liver and kidney impairment.

MYTREXATE 2.5 TABLET is not recommended in children for the management of psoriasis and rheumatoid arthritis. However, MYTREXATE 2.5 TABLET can be used with caution in children to manage polyarticular juvenile idiopathic arthritis, which is characterized by the involvement of five or more joints that are of severe, active, juvenile, and idiopathic character. Consult the doctor before taking MYTREXATE 2.5 TABLET.

In addition, caution must be exercised by patients suffering from lung disorders, blood disorders, and gastric disorders before taking MYTREXATE 2.5 TABLET.

Care must be taken to avoid taking products containing caffeine, such as black tea, coffee, and cold drinks, while taking MYTREXATE 2.5 TABLET.

The common side effects seen after taking MYTREXATE 2.5 TABLET are headache, nausea, vomiting, dizziness, and altered levels of blood cells. Consult a doctor if any of the above side effects worsen after taking MYTREXATE 2.5 TABLET.

• active rheumatoid arthritis
• psoriasis
• arthritis in patients suffering from psoriasis (psoriatic arthritis)
• relapsed and refractory (unaffected by other conventional managements) Non-Hodgkin’s Lymphoma
• polyarticular juvenile idiopathic arthritis

Before taking MYTREXATE 2.5 TABLET, inform your doctor if you are taking any of the following medicines:

• medicines used to manage bacterial infections (Ex. amoxicillin, ciprofloxacin)
• medicines used to increase urine excretion (Ex. frusemide)
• medicines used to manage increased sugar levels (Ex. metformin)
• medicines used to manage fits (Ex. phenytoin)
• medicines used to manage increased cholesterol levels (Ex. cholestyramine)
• medicines used to manage gout (Ex. probenecid)
• medicines to manage reduced folic acid levels (Ex. folic acid preparations)
• medicines used to manage severe heartburn or ulcers (Ex. omeprazole)
• other medicines used to manage rheumatoid arthritis (Ex. leflunomide)
• medicines that can be harmful to the liver (Ex. sulfasalazine)
• medicines used in the management of cancer (Ex. doxorubicin, cisplatin, and mercaptopurine)
• medicines used to manage pain (Ex. ibuprofen, naproxen, diclofenac)
• other medicines used to manage rheumatoid arthritis and psoriasis (Ex. leflunomide, phenylbutazone, or amidopyrine)
• medicines used to manage asthma (Ex. theophylline)
• medicines used in organ transplantation (Ex. cyclosporin, azathioprine)
• medicines used to induce sleep (Ex. phenobarbitone)
• medicines used to induce calmness and relieve anxiety (Ex. diazepam)
• medicines used for oral contraception (Ex. estrogen)
• medicines used to manage skin conditions (Ex. retinoids)
• medicines used to manage malaria (Ex. pyrimethamine)
• medicines that contain live vaccines (Ex. MMR vaccine)
• medicines used for general anesthesia and pain relief (Ex. nitrous oxide)
• medicines used to manage heart problems (Ex. amiodarone)
• medicines used to manage heart failure (Ex. digoxin)
• medicines used for the management of various inflammatory conditions like skin diseases and allergic reactions (Ex. hydrocortisone)

B. Drug-Food interactions:

It is recommended to avoid the consumption of drinks containing caffeine, such as black tea, coffee, and soft drinks, along with MYTREXATE 2.5 TABLET, to manage dehydration.

Overdosage:

If you or someone else accidentally takes too much MYTREXATE 2.5 TABLET, it is recommended to consult your doctor immediately. Symptoms of overdosage with MYTREXATE 2.5 TABLET are an easy tendency to bruise or bleed, nausea, vomiting, and unusual weakness, along with the development of mouth sores and ulcers.

A: MYTREXATE 2.5 TABLET is used to manage active rheumatoid arthritis in adults, which is a form of severe arthritis occurring due to unknown reasons (idiopathic) and old age and is non-responsive to conventional painkillers (such as non-steroidal anti-inflammatory drugs, Ex. Aceclofenac). MYTREXATE 2.5 TABLET is also used to manage the polyarthritic forms (characterized by the involvement of five or more joints), which are severe, active, and idiopathic in nature and affect young people (Juvenile Idiopathic Arthritis, JIA).

Q: Can I take MYTREXATE 2.5 TABLET in pregnancy?

A: MYTREXATE 2.5 TABLET is not recommended for use in pregnant women and/or in women who are planning pregnancy because it can be harmful for the fetus (a growing baby in the womb). Consult your doctor before taking MYTREXATE 2.5 TABLET.

Q: Can I take MYTREXATE 2.5 TABLET if I’m breastfeeding a baby?

A: MYTREXATE 2.5 TABLET is not recommended for nursing mothers due to a lack of safety data. Consult your doctor before taking MYTREXATE 2.5 TABLET.

Q: Can MYTREXATE 2.5 TABLET be taken by children?

A: MYTREXATE 2.5 TABLET is not recommended in children for the management of psoriasis and rheumatoid arthritis. However, MYTREXATE 2.5 TABLET can be used with caution in children to manage polyarticular juvenile idiopathic arthritis. Your doctor will prescribe the right dose depending on your child’s age, body weight, and health condition. Consult your doctor for advice before taking MYTREXATE 2.5 TABLET.

Q: Can MYTREXATE 2.5 TABLET be used by the elderly?

A: MYTREXATE 2.5 TABLET is recommended to be administered with caution and in a lower dosage to elders due to diminished function of the liver and kidneys and reduced folate levels in the blood in old age. Also, it is recommended to closely monitor the elderly, taking MYTREXATE 2.5 TABLET for the identification of possible side effects. Consult the doctor before taking MYTREXATE 2.5 TABLET.

Q: Is there any specific food to avoid while taking MYTREXATE 2.5 TABLET?

A: It is recommended to avoid the consumption of drinks containing caffeine, such as black tea, coffee, and soft drinks, along with MYTREXATE 2.5 TABLET, to manage dehydration.

2. Brown, P.M., Pratt, A.G. and Isaacs, J.D., 2016. Mechanism of action of Methotrexate in Rheumatoid Arthritis and the search for biomarkers.  Nature Reviews Rheumatology. [Published on 27th October 2016] [Accessed on 3rd February 2024] https://www.nature.com/articles/nrrheum.2016.175

3. Orion Corporation. Electronic Medicines Compendium (EMC) U.K [Revised in August 2023] [Accessed on 3rd February 2024] https://www.medicines.org.uk/emc/files/pil.1376.pdf

4. Cipla. Methotrexate. [Revised on 13th April 2020] [Accessed on 3rd February 2024] https://www.cipla.com/sites/default/files/Methotrexate%202.5%20mg%20%E2%80%93%20Patient%20Card%20-%20Risk%20Minimisation%20Information%20for%20Patients.pdf

5. Accord Healthcare Inc. U.S.A. [Revised in December 2021] [Accessed on 3rd February 2024] https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=874c7f43-a3be-4236-89cc-24c44e3c5813&type=display#section-9

6. Teva Women's Health, Inc. [Revised in April 2021] [Accessed on 3rd February 2024] https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=e942f8db-510f-44d6-acb5-b822196f5e8c&type=display#section-9

7. Pfizer Healthcare Ireland. [Revised in September 2020] [Accessed on 3rd February 2024] http://www.hpra.ie/img/uploaded/swedocuments/Licence_PA0822-206-005_23092020105544.pdf

8. Pfizer Australia Pty Ltd. [Revised in August 2021] [Accessed on 3rd February 2024] https://www.nps.org.au/assets/medicines/152212ff-3721-4bba-b3cc-a53300ff0e7d.pdf

9. Imutaj. Taj Pharma. [Accessed on 3rd February 2024] https://tajpharma.in/portfolio-item/methotrexate-tablets-ip-5mg-imutaj-taj-pharma/